Opus Genetics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
IRD on Nasdaq
Industry
Pharmaceutical Preparations
Location
37000 Grand River Ave., Suite 120, Farmington Hills, MI

Insiders trading volume in the past year

Opus Genetics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Foundation Fighting Blindness Retinal Degeneration Fund Director, Other* $4.53M Oct 22, 2024
Bernhard Hoffmann SVP of Corp. Dev. $531K Jan 18, 2024
George Magrath Chief Executive Officer $505K +$159K +45.9% Nov 15, 2024
Richard J. Rodgers Director $422K Jun 11, 2024
Benjamin R. Yerxa President, Director $337K +$9.83K +3% Nov 21, 2024
Jay Pepose Director $319K Jun 11, 2024
Nirav S. Jhaveri Chief Financial Officer $315K +$21K +7.14% Mar 21, 2024
Ronil A. Patel Chief Business Officer $296K Jan 10, 2024
Rabourn Amy Zaremba SVP of Finance $270K Jan 18, 2024
Susan Benton Director $247K Jun 11, 2024
James Manuso Director $233K Jun 11, 2024
Jean Bennett Director $177K Oct 22, 2024
Mina Sooch President and CEO, Director $163K Jan 10, 2023
Sean Ainsworth Director $156K Jun 11, 2024
Ashwath Jayagopal Chief Scientific & Dev. Ofc. $139K +$6.18K +4.67% May 22, 2024
Cam Gallagher Director $136K Jun 11, 2024
Joseph K. Schachle Chief Operating Officer $4.1K +$4.1K Mar 21, 2024
Adrienne L. Graves Director Oct 22, 2024

Recent Insider Transactions by Companies or Individuals for Opus Genetics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.